Ipsilateral silent period: A marker of callosal conduction abnormality in early relapsing-remitting multiple sclerosis?

被引:31
|
作者
Jung, Patrick
Beyerle, Astrid
Hurnpich, Marek
Neumann-Haefelin, Tobias
Lanfermann, Heinrich
Ziemann, Ulf
机构
[1] Univ Frankfurt, Dept Neurol, D-60528 Frankfurt, Germany
[2] Univ Frankfurt, Inst Neuroradiol, D-6000 Frankfurt, Germany
关键词
ipsilateral silent period; central motor conduction time; transcranial magnetic stimulation; corpus callosuni; relapsing-remitting multiple sclerosis;
D O I
10.1016/j.jns.2006.08.008
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: The corpus callosum (CC) is commonly affected in multiple sclerosis (MS). The ipsilateral silent period (iSP) is a putative electrophysiological marker of callosal demyelination. The purpose of this study was to re-assess, under recently established optimised protocol conditions [Jung P., Ziemann U. Differences of the ipsilateral silent period in small hand muscles. Muscle Nerve in press.], its diagnostic sensitivity in MS, about which conflicting results were reported in previous studies. Methods: ISP measurements (onset, duration, and depth) were obtained in the abductor pollicis brevis (APB) muscle of either hand in 49 patients with early relapsing-remitting MS (RRMS) (mean EDSS, 1.3). Standard central motor conduction times to the APB (CMCTAPB) and tibial anterior muscles (CMCTTA), and magnetic resonance images (MRI) were also obtained. Results: ISP measurements showed a similar diagnostic sensitivity (28.6%) as CMCTAPB (24.5%), while diagnostic sensitivities of CMCTTA (69.4%) and MRI of the CC (78.6%) were much higher. Prolongation of iSP duration was the most sensitive single iSP measure. ISP prolongation occurred more frequently when CMCTAPB to the same hand was also prolonged (40.0% vs. 8.4%, p < 0.000 1). The correlation between iSP duration and CMCTAPB was significant (Pearson's r=0.24, p < 0.02), suggesting that iSP duration can be contaminated by demyclination of the contralateral corticospinal tract. ISP duration did not correlate with MRI abnon-nalities of the CC. Conclusions: ISP measures are neither a sensitive nor a specific marker of callosal conduction abnormality in early RRMS. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:133 / 139
页数:7
相关论文
共 50 条
  • [21] Cellular sources of dysregulated cytokines in relapsing-remitting multiple sclerosis
    Jeppe Romme Christensen
    Lars Börnsen
    Dan Hesse
    Martin Krakauer
    Per Soelberg Sørensen
    Helle Bach Søndergaard
    Finn Sellebjerg
    Journal of Neuroinflammation, 9
  • [22] Disease-modifying therapies in relapsing-remitting multiple sclerosis
    Gonzalez-Andrade, Fabricio
    Luis Alcaraz-Alvarez, Jose
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2010, 6 : 365 - 373
  • [23] Discontinuation and dose reduction of rituximab in relapsing-remitting multiple sclerosis
    Boremalm, Malin
    Sundstrom, Peter
    Salzer, Jonatan
    JOURNAL OF NEUROLOGY, 2021, 268 (06) : 2161 - 2168
  • [24] Facial emotion recognition in patients with relapsing-remitting multiple sclerosis
    Fereydouni, Soodabe
    Hadianfard, Habib
    Ashjazadeh, Nahid
    NEUROLOGY ASIA, 2019, 24 (04) : 327 - 332
  • [25] Novel Therapeutic Approaches to Multiple Sclerosis: Neuroprotective Drugs for Relapsing-Remitting Multiple Sclerosis
    Pugliese, Marco
    Espinosa-Parrilla, Juan F.
    Bustos, Javier
    Campas, Clara
    de Frias, Merce
    Sorrosal, Georgina
    ADVANCES IN NEUROIMMUNE BIOLOGY, 2013, 4 (03) : 187 - 204
  • [26] Cellular sources of dysregulated cytokines in relapsing-remitting multiple sclerosis
    Christensen, Jeppe Romme
    Bornsen, Lars
    Hesse, Dan
    Krakauer, Martin
    Sorensen, Per Soelberg
    Sondergaard, Helle Bach
    Sellebjerg, Finn
    JOURNAL OF NEUROINFLAMMATION, 2012, 9
  • [27] Cortical thickness and surface area relate to specific symptoms in early relapsing-remitting multiple sclerosis
    Nygaard, Gro O.
    Walhovd, Kristine B.
    Sowa, Piotr
    Chepkoech, Joy-Loi
    Bjornerud, Atle
    Due-Tonnessen, Paulina
    Landro, Nils I.
    Damangir, Soheil
    Spulber, Gabriela
    Storsve, Andreas B.
    Beyer, Mona K.
    Fjell, Anders M.
    Celius, Elisabeth G.
    Harbo, Hanne F.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 (04) : 402 - 414
  • [28] Multimodal evoked potentials measure and predict disability progression in early relapsing-remitting multiple sclerosis
    Jung, P.
    Beyerle, A.
    Ziemann, U.
    MULTIPLE SCLEROSIS, 2008, 14 (04): : 553 - 556
  • [29] Established disease-modifying treatments in relapsing-remitting multiple sclerosis
    Oh, Jiwon
    O'Connor, Paul W.
    CURRENT OPINION IN NEUROLOGY, 2015, 28 (03) : 220 - 229
  • [30] Fingolimod A Review of its Use in the Management of Relapsing-Remitting Multiple Sclerosis
    Scott, Lesley J.
    CNS DRUGS, 2011, 25 (08) : 673 - 698